Adverse hematologic effects of drugs.
D000743:Anemia, Hemolytic / Q000139:chemically induced; D000748:Anemia, Macrocytic / Q000139:chemically induced; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D001791:Blood Platelet Disorders / Q000139:chemically induced; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000139:chemically induced; D006402:Hematologic Diseases / Q000139:chemically induced*; D006410:Hematopoiesis / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced; D010634:Phenobarbital / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D011247:Pregnancy; D011324:Primidone / Q000009:adverse effects; D012713:Serum Sickness / Q000139:chemically induced; D013163:Splenomegaly / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced / Q000276:immunology; D014149:Tranquilizing Agents / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D000928:Antidepressive Agents; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D014149:Tranquilizing Agents; D011324:Primidone; D010672:Phenytoin; D001241:Aspirin; D010634:Phenobarbital